Reducing opioid overdose deaths in Massachusetts
MassHEAL - Reducing overdose deaths by 40% (2019-2023)
['FUNDING_OTHER'] · BOSTON MEDICAL CENTER · NIH-10388200
This study is working to help people in 16 communities in Massachusetts who are struggling with opioid use by offering better treatment options and support, and it will see how these new programs compare to the usual care to help reduce overdose deaths.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BOSTON MEDICAL CENTER (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10388200 on ClinicalTrials.gov |
What this research studies
This research aims to significantly reduce opioid overdose deaths in Massachusetts by implementing a tailored suite of programs in 16 high-risk communities. By using a data-driven approach and the Communities That Care model, the project will identify individuals with opioid use disorder and provide them with access to effective treatments and risk reduction strategies. The research will compare the outcomes of communities receiving enhanced treatment options against those receiving standard care, allowing for a comprehensive evaluation of the interventions' effectiveness.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living in Massachusetts who are at high risk for opioid overdose, particularly those with opioid use disorder.
Not a fit: Patients who do not reside in Massachusetts or who do not have a history of opioid use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a substantial decrease in opioid overdose deaths, improving public health and saving lives.
How similar studies have performed: Previous research has shown success in reducing overdose deaths through community-based interventions, indicating that this approach has potential for impactful results.
Where this research is happening
BOSTON, UNITED STATES
- BOSTON MEDICAL CENTER — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SAMET, JEFFREY H. — BOSTON MEDICAL CENTER
- Study coordinator: SAMET, JEFFREY H.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.